GeneNews Ltd (TSX: GEN), a life science equipments company, is featured as today’s top stock with strong share price momentum breaking the short term Daily Moving Average (DMA). Its stock jumped over 16% during the last two consecutive trading days with a greater than average number of shares exchanging hands. In the last session, GEN was among the top performers in the Canadian healthcare sector having gained 21.3% breaking the 30-day and 50-day DMA at C$1.23 & C$1.50. The stock closed at C$1.48 while recording huge volumes of 222,677 shares. During the past 5-trading sessions, GEN climbed 35.8% with 5-day daily average trading volumes of 106,579 shares, while the stock accumulated over 23% during the past month with 30-day daily average trading volumes of 62,220 shares. The stock has provided returns of over 76% year to date.
Company Description:
GeneNews Ltd (TSX: GEN) develops and markets diagnostic kits. The company produces kits that help diagnose cancer, cardiovascular diseases, central nervous system disorders, and arthritis from a blood sample.
1-Year Stock Chart:
Source: Bloomberg
